Meiji Yasuda Life Insurance Co Sells 9,422 Shares of Docusign Inc. $DOCU

Key Points

• Meiji Yasuda Life Insurance Co reduced its stake in Docusign by 62.1%, owning 5,754 shares worth $468,000 after selling 9,422 shares in the first quarter.
• Several firms have raised their price targets for Docusign, with Robert W. Baird setting a target of $90, while Royal Bank of Canada increased theirs to $95, reflecting a generally positive view on the stock.
• Docusign reported better-than-expected quarterly earnings, with $0.92 EPS on revenue of $800.64 million, exceeding analyst expectations, while also announcing a $1 billion share buyback program.

Meiji Yasuda Life Insurance Co cut its holdings in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 62.1% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,754 shares of the company's stock after selling 9,422 shares during the period. Meiji Yasuda Life Insurance Co's holdings in Docusign were worth $468,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Palogic Value Management L.P. boosted its stake in Docusign by 2.2% in the first quarter. Palogic Value Management L.P. now owns 5,438 shares of the company's stock worth $443,000 after purchasing an additional 117 shares in the last quarter. Wealthspire Advisors LLC lifted its position in Docusign by 1.9% during the 1st quarter. Wealthspire Advisors LLC now owns 6,579 shares of the company's stock worth $536,000 after buying an additional 122 shares in the last quarter. Foundry Partners LLC grew its holdings in Docusign by 1.5% during the 1st quarter. Foundry Partners LLC now owns 8,491 shares of the company's stock worth $691,000 after acquiring an additional 125 shares during the last quarter. Bessemer Group Inc. grew its holdings in Docusign by 27.5% during the 1st quarter. Bessemer Group Inc. now owns 602 shares of the company's stock worth $49,000 after acquiring an additional 130 shares during the last quarter. Finally, Brooklyn Investment Group increased its position in Docusign by 24.9% in the 1st quarter. Brooklyn Investment Group now owns 702 shares of the company's stock valued at $57,000 after acquiring an additional 140 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on DOCU shares. UBS Group set a $95.00 target price on shares of Docusign in a research report on Friday, September 5th. Wells Fargo & Company upped their price objective on Docusign from $80.00 to $85.00 and gave the stock an "equal weight" rating in a report on Friday, September 5th. Morgan Stanley lifted their target price on Docusign from $86.00 to $90.00 and gave the company an "equal weight" rating in a research note on Monday, September 8th. Argus restated a "hold" rating on shares of Docusign in a research report on Monday, September 8th. Finally, Wall Street Zen upgraded Docusign from a "hold" rating to a "buy" rating in a report on Saturday. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $94.14.

Docusign Stock Down 0.1%

NASDAQ DOCU traded down $0.05 on Friday, reaching $80.19. The company had a trading volume of 2,170,380 shares, compared to its average volume of 3,118,836. Docusign Inc. has a 52 week low of $55.14 and a 52 week high of $107.86. The stock's 50 day moving average is $75.74 and its 200-day moving average is $79.25. The stock has a market cap of $16.13 billion, a price-to-earnings ratio of 60.29, a PEG ratio of 4.21 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.84 by $0.08. The firm had revenue of $800.64 million for the quarter, compared to analysts' expectations of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company's revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the business earned $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, analysts forecast that Docusign Inc. will post 1.17 EPS for the current year.

Docusign announced that its Board of Directors has initiated a stock repurchase program on Thursday, June 5th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to purchase up to 6.6% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its shares are undervalued.

Insider Activity

In other Docusign news, Director Teresa Briggs sold 364 shares of the stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $79.39, for a total value of $28,897.96. Following the sale, the director directly owned 9,170 shares in the company, valued at approximately $728,006.30. This trade represents a 3.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Robert Chatwani sold 983 shares of the business's stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $79.39, for a total transaction of $78,040.37. Following the completion of the transaction, the insider directly owned 71,143 shares of the company's stock, valued at $5,648,042.77. This trade represents a 1.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 79,899 shares of company stock worth $6,090,570 over the last three months. Company insiders own 1.01% of the company's stock.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.